Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
-
If you are wondering whether Danaher at around US$188.87 is starting to look attractive again, the stock’s valuation metrics offer some clear signals that are worth unpacking.
-
Over the very short term, Danaher has risen 6.2% over the last 7 days and 9.8% over the last 30 days, even though the stock is still down 18.0% year to date and has declined 5.4% over the past year.
-
These moves sit against a backdrop where investors have been reassessing large healthcare and life sciences stocks, with sentiment shifting between defensive positioning and concern about longer term growth drivers….






